TraceLink Announces Speaker Lineup and Advisory Board for FutureLink Barcelona


NORTH READING, Mass., April 15, 2019 /PRNewswire/ -- TraceLink, Inc., the world's largest integrated digital supply network providing real-time information sharing for better patient outcomes, today announced the speaker lineup and newly introduced Advisory Board for FutureLink Barcelona.


The annual event, taking place June 11-13, 2019 at the Hesperia Barcelona Tower Hotel, sees leaders from across the life sciences industry in Europe, gather to collaborate on the digital transformation of the pharmaceutical supply chain.

Speakers will explore how data can drive innovation, transform business operations, and improve patient outcomes with sessions on a range of subject areas including global regulation updates, digital recalls, analytics, supplier collaboration and creating value beyond compliance.

Featured industry speakers at FutureLink Barcelona include:

  • Frank Binder, Corporate Officer and Head of Supply Chain Management, Santen
  • Naseem Amin, CEO and Director, GMP-Orphan
  • Luca Pezzano, Operations Director, IBI Lorenzini
  • Nicolas Florin, CEO, Swiss Medicines Verification Organization
  • Bjoern Rosner, Global Serialization Program Lead, Biogen
  • Magdalena Wohlfarth, Senior Manager Enterprise Application of Track & Trace, BBRAUN AG
  • Carlos Ruiz, Pharma Operations Leader, Almirall
  • Dr Martin Hug, Chief Pharmacist, University Medical Center Freiburg
  • Emmanouela Nikolakopoulou, Legal Counsel, European Medicines Verification Organization
  • Robert Hughes, Global Serialization Program Manager, DHL
  • Pasi Kemppainen, Global Serialization and Traceability Management Advisor, Santen  

"With the FMD deadline passed, FutureLink Barcelona has been designed to address the ongoing business value organizations can achieve from their serialization investment including managing drug recalls and shortages, driving efficiencies through supplier collaboration, engaging patients and caregivers through digital health, and leveraging analytics in the supply chain to make more informed decisions," said Shabbir Dahod, president and CEO, TraceLink. "FutureLink is the only industry event that brings together the end-to-end supply chain, and this is strongly represented in our growing lineup of speakers, who will explore the opportunities derived from a fully integrated digital supply network."

The strategic direction for the FutureLink Barcelona conference program, speakers, and educational content will be guided by a newly introduced Advisory Board. The Advisory Board will be comprised of the industry's most credible and distinguished thought leaders throughout various areas of life sciences, including Frank Binder, Global Head of Supply Chain Management, Santen and Naseem Amin, CEO, GMP Orphan.

"To date, the pharma industry has been very focused on implementing serialization, and now companies are starting to search for supply chain efficiencies and opportunities to create new services by improving communications with partners and patients by utilizing the digital network that has been created to share serialization data," said Mr. Binder. "The industry needs a platform to join forces on these topics and discuss the digital transformation that is happening within the pharma supply chain and I am looking forward to being a part of this discussion." 

"The value of serialization and digital information sharing will revolutionize the healthcare industry and this year's FutureLink conference program is designed to foster discussion that will shape the future of healthcare and digital drug supply by leveraging new technologies geared toward providing better patient outcomes," said Mr. Amin.

For more information, to register, or view the agenda, please visit:

About TraceLink
TraceLink is the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. The TraceLink digital supply network is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit

TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.


Cision View original content to download multimedia:

SOURCE TraceLink


Back to news